ISO 22716:2007 - Cosmetics GMP Internal Auditor Free Practice Test — 30 Questions

Question 1

During an internal audit of a cosmetic manufacturing facility, an auditor observes that the documented procedure for the cleaning validation of a specific filling machine has not been consistently followed by the production team, leading to a minor residue detection in the subsequent batch. The auditor needs to determine the most effective action to ensure compliance and prevent recurrence, considering the principles of ISO 22716:2007.

Accepted Answer

Recommend a review and update of the cleaning validation procedure to incorporate clearer instructions and enhanced verification steps, followed by retraining of relevant personnel.

Question 2

During an internal audit of a cosmetic manufacturing facility, a significant non-conformity was identified concerning the inadequate traceability of a key botanical extract, preventing the precise identification of its specific production batch and origin. The company implemented a corrective action plan involving a revised incoming raw material inspection and labeling procedure. As the internal auditor responsible for follow-up verification, which of the following actions would most effectively confirm the successful implementation and efficacy of this corrective action?

Accepted Answer

Select a statistically significant sample of recently received raw material batches and trace their batch information forward and backward through production and inventory records to verify the new labeling system's functionality and the material's traceability.

Question 3

During an internal audit of a cosmetic manufacturing facility adhering to ISO 22716:2007, an auditor discovers that the batch records for a recently produced facial serum do not explicitly detail the precise ambient temperature and humidity conditions during the critical mixing phase, a parameter known to influence the stability of certain active ingredients. This omission represents a deviation from the company\'s own documented Standard Operating Procedure (SOP) for this product, which mandates the recording of these environmental parameters. What is the most appropriate immediate action for the internal auditor to take in response to this finding?

Accepted Answer

Document the non-conformity in the audit report, clearly stating the deviation from the SOP and the potential impact on product quality, and ensure the responsible department initiates a root cause analysis and corrective action plan.

Question 4

During an internal audit of a cosmetic manufacturing facility, an auditor observes that the ingredient list displayed on the final product\'s packaging for a new facial serum does not precisely match the detailed ingredient list documented in the company\'s internal \"Master Formula\" document. The Master Formula is the approved technical blueprint for the product. Which of the following documents would the auditor primarily refer to as the definitive standard to assess the compliance of the ingredient declaration on the packaging?

Accepted Answer

The product's official specification document

Question 5

During an internal audit of a cosmetic manufacturing facility, an auditor observes that a batch of a critical raw material, identified by lot number R45-B7, is being used in the production of a facial serum. Upon cross-referencing with the approved supplier list and material specifications, the auditor discovers that lot R45-B7 was not sourced from an approved vendor and its accompanying Certificate of Analysis (CoA) does not meet the specified purity criteria for the active ingredient. What is the most appropriate immediate action for the internal auditor to recommend and ensure is implemented to mitigate the risk to product quality and consumer safety, in accordance with ISO 22716:2007 principles?

Accepted Answer

Immediately halt the production line utilizing the unapproved raw material lot until the deviation is fully investigated and resolved.

Question 6

During an internal audit of a cosmetic manufacturing facility, an auditor reviews records from a previous audit that identified a recurring issue with inconsistent batch labeling. The company provided a corrective action report (CAR) detailing steps taken, including retraining staff and updating the labeling procedure. What is the most critical step for the auditor to take to ensure the effectiveness of the implemented corrective actions and the overall GMP compliance?

Accepted Answer

Verify that the retraining was conducted and the updated procedure was implemented, and then assess the subsequent batch records for evidence of consistent and accurate labeling.

Question 7

During an internal audit of a cosmetic manufacturing plant, an auditor observes production personnel in the primary mixing area wearing standard company uniforms that appear to have minor stains, and no additional disposable overgarments are being worn over these uniforms. The facility\'s documented GMP procedures require personnel to wear clean, appropriate protective clothing in all production zones. What is the most accurate and immediate finding for the auditor to document regarding this observation in relation to ISO 22716:2007 requirements?

Accepted Answer

Non-conformity related to inadequate control of personnel protective clothing, posing a risk of product contamination.

Question 8

During an internal audit of a cosmetic manufacturing facility, an auditor identifies a significant non-conformity concerning inadequate pest control measures in the raw material storage area, evidenced by visible signs of rodent droppings. The company\'s quality assurance department submits a corrective action plan detailing the installation of new, high-density sealing strips on all external doors and windows of the storage facility. What is the most appropriate subsequent action for the internal auditor to take to ensure the effectiveness of the implemented corrective action?

Accepted Answer

Schedule a follow-up verification activity specifically to assess the effectiveness of the new sealing strips and the overall pest control in the raw material storage area.

Question 9

A cosmetic manufacturer discovers a potential deviation in the stability testing of a recently produced batch of facial serum. While the deviation is not yet confirmed as a critical safety issue, preliminary findings suggest a possible reduction in efficacy over time. The affected batch has been placed on hold, and no further shipments have been made to distributors or retailers. The company is currently conducting a thorough investigation to determine the root cause and the extent of the impact. What is the most appropriate immediate action to manage this situation in accordance with ISO 22716:2007 principles?

Accepted Answer

Initiate a product withdrawal of the affected batch from the distribution chain.

Question 10

During an internal audit of a cosmetic manufacturer adhering to ISO 22716:2007, an auditor discovers that a batch of finished skincare products has been released for distribution despite a documented failure in the primary packaging\'s seal integrity during a final quality control check. This failure was noted in the batch records but was apparently overlooked by the quality assurance department during the release process. What is the most critical immediate action the internal auditor must take upon identifying this significant deviation?

Accepted Answer

Document the critical non-conformity and immediately report it to senior management, recommending the quarantine and recall of the affected product batch.

Question 11

During an internal audit of \"AuraGlow Cosmetics,\" an auditor observes that a batch of facial serum was filled into containers where the labels were misaligned by 1.5mm, exceeding the documented procedural tolerance of +/- 1mm. While this specific deviation did not compromise the product\'s safety, efficacy, or quality, what is the most appropriate auditor action according to ISO 22716:2007 principles for GMP internal auditing?

Accepted Answer

Initiate a Corrective and Preventive Action (CAPA) process to investigate the root cause of the label misalignment and implement measures to prevent recurrence.

Question 12

During an internal audit of a cosmetic manufacturing facility, an auditor discovers a recurring issue with inconsistent batch labeling, previously identified in a prior audit. The company has documented corrective actions taken to address this. What is the most critical verification step for the auditor to confirm the effectiveness of the company\'s CAPA system in this instance?

Accepted Answer

Confirming that the implemented corrective actions have demonstrably prevented the reoccurrence of the inconsistent batch labeling.

Question 13

During an internal audit of a cosmetic manufacturing facility adhering to ISO 22716:2007, an auditor reviewing the production records for \"AuraGlow Radiance Serum\" discovers a discrepancy. The finished product batch record for batch AG-2023-005 states that raw material \"Hyaluronic Acid Concentrate\" with supplier batch number HACC-B789 was used. However, the incoming goods log and the inventory management system indicate that supplier batch HACC-B789 was allocated to product \"VelvetSkin Moisturizer\" batch VS-2023-012, and that raw material \"Hyaluronic Acid Concentrate\" supplier batch HACC-B801 was allocated to AG-2023-005. What is the most critical step the auditor must take to verify the actual raw material used in AG-2023-005 and ensure compliance with traceability requirements?

Accepted Answer

Compare the supplier batch number recorded in the finished product batch record (AG-2023-005) with the supplier's Certificate of Analysis and the incoming goods documentation for that specific supplier batch.

Question 14

During an internal audit of a cosmetic manufacturing facility producing lipsticks, an auditor discovers a batch of finished product containing visible foreign particulate matter. The company\'s standard operating procedure for handling such deviations involves immediate quarantine and potential destruction of the affected batch. However, the auditor suspects this might be a symptom of a more systemic issue. Considering the principles of ISO 22716:2007, which of the following audit findings and recommended corrective actions would most effectively address the underlying cause of the contamination and prevent recurrence?

Accepted Answer

Identify the specific production stage where the foreign particulate matter was introduced by reviewing batch records, cleaning logs, and conducting process observations, and implement targeted preventative measures at that stage.

Question 15

During an internal audit of a cosmetic manufacturing facility, an auditor identifies a recurring non-conformity related to the inconsistent application of cleaning procedures for production equipment between batches. The company\'s quality assurance department has submitted a corrective action plan that includes retraining personnel and updating the cleaning logbook. What is the auditor\'s primary responsibility in verifying the effectiveness of this corrective action plan according to ISO 22716:2007 principles?

Accepted Answer

Confirming that the retraining has been conducted and reviewing evidence that the updated logbook is being utilized correctly, while also assessing if the frequency and nature of equipment-related deviations have demonstrably decreased post-implementation.

Question 16

An internal auditor is reviewing the procedure for handling returned cosmetic products at a manufacturing facility. The facility receives a batch of finished products due to a customer complaint about inconsistent texture. The auditor needs to assess the effectiveness of the company\'s process for managing these returned items to ensure compliance with ISO 22716:2007. Which of the following actions by the auditor best demonstrates an understanding of the standard\'s requirements for returned products?

Accepted Answer

Verifying that a documented procedure exists for the evaluation and disposition of returned products, ensuring that returned items are quarantined and assessed for potential reconditioning or destruction based on risk and quality assurance principles.

Question 17

Following an internal audit that identified a non-conformity regarding the inadequate segregation of raw materials from finished goods in a cosmetic manufacturing facility, the company provided a corrective action plan detailing new storage protocols and staff training. As an internal auditor for ISO 22716:2007, what is the most critical next step to ensure the effectiveness of the implemented measures?

Accepted Answer

Conduct a follow-up audit specifically to verify the implementation and effectiveness of the new storage protocols and staff training.

Question 18

During an internal audit of a cosmetic manufacturing facility, an auditor discovers that a specific batch of a key raw material, identified by batch number RM-XYZ-789, was found to be contaminated with an undeclared allergen. The company produces multiple finished cosmetic products that utilize this raw material. What is the primary focus for the internal auditor to assess the effectiveness of the company\'s Good Manufacturing Practices (GMP) in response to this discovery, considering ISO 22716:2007 requirements?

Accepted Answer

The ability to trace all finished product batches that incorporated raw material batch RM-XYZ-789 and the effectiveness of the recall procedure for those identified batches.

Question 19

During an internal audit of a cosmetic manufacturing facility, an auditor observes a production line operator directly handling a batch of finished, packaged lip balm tubes without wearing any protective gloves. The operator is not engaged in any task that would necessitate direct skin contact with the product itself, such as sampling or quality control inspection. The facility\'s GMP procedures, aligned with ISO 22716:2007, mandate the use of gloves for all personnel involved in direct product handling to prevent contamination. What is the most appropriate immediate action for the auditor to take in this situation?

Accepted Answer

Document the observation as a non-conformity, referencing the relevant clause of ISO 22716:2007 concerning personnel hygiene and protective clothing, and assess the potential risk of contamination to the product.

Question 20

During an internal audit of a cosmetic manufacturing facility adhering to ISO 22716:2007, an auditor is reviewing the personnel training records and the implementation of hygiene protocols. The auditor observes that while some employees have received general safety training, there is no specific documented evidence of training related to the prevention of microbial contamination during the handling of raw materials and finished products, nor is there clear evidence of competency assessment for tasks involving direct product contact. What is the most critical finding for the internal auditor to report regarding the organization\'s compliance with ISO 22716:2007?

Accepted Answer

The absence of documented, specific training on preventing microbial contamination during material handling and a lack of competency assessment for personnel involved in direct product contact.

Question 21

During an internal audit of a cosmetic manufacturing facility adhering to ISO 22716:2007, an auditor observes that a critical raw material, \"Aromasol X,\" intended for a new fragrance line, was received and placed into production inventory without its accompanying Certificate of Analysis (CoA). The facility’s standard operating procedure (SOP) for raw material reception mandates that all incoming materials must be accompanied by a CoA, which is to be verified against the material\'s specifications before release for use. What is the most appropriate initial finding and subsequent action for the auditor to document regarding this observation?

Accepted Answer

Document a non-conformance related to the failure to verify incoming raw material identity and quality as per the documented reception procedure, and investigate the subsequent handling and disposition of the "Aromasol X" batch.

Question 22

During an internal audit of a cosmetic manufacturing facility, an auditor observes a pallet of returned raw material, specifically a batch of a key botanical extract, situated in a designated quarantine area. The customer cited a slight deviation in color as the reason for return. While the area is marked for quarantined goods, the specific pallet in question lacks any distinct labeling indicating its status as \"Quarantined,\" \"On Hold,\" or \"Under Investigation.\" Furthermore, the accompanying documentation for this returned batch is not immediately accessible at the point of storage, and the material\'s ultimate disposition (e.g., re-work, destruction, return to supplier) has not yet been formally determined or recorded in the material management system. What is the most critical finding for the auditor to document regarding this situation in relation to ISO 22716:2007?

Accepted Answer

The absence of clear, specific identification on the returned raw material pallet, coupled with the pending formal disposition, represents a significant risk of accidental reintroduction into the production process, thereby violating material control and traceability requirements.

Question 23

During an internal audit of a cosmetic manufacturing facility adhering to ISO 22716:2007, an auditor identifies a non-conformity regarding inadequate cleaning validation procedures for shared processing equipment, leading to potential cross-contamination risks. The company proposes a corrective action: updating the Standard Operating Procedure (SOP) for equipment cleaning and conducting a one-time training session for the production staff on the revised SOP. The auditor needs to verify the effectiveness of this corrective action. Which of the following actions by the auditor would best demonstrate the verification of effectiveness for this corrective action?

Accepted Answer

Requesting documented evidence that the updated SOP has been implemented and reviewing subsequent batch records for the affected equipment to confirm the absence of cross-contamination indicators.

Question 24

During an internal audit of a cosmetic manufacturing facility, an auditor reviews the batch production records for a popular facial serum. The records indicate that the finished product batch, designated as FS-2023-B12, was produced on October 15, 2023. However, upon cross-referencing with the raw material dispensing logs, the auditor discovers that the exact quantity of \"Aqua Purificata\" used in this specific batch is not clearly documented in the batch record, with only a general notation of \"as per formula.\" The formula itself specifies a precise percentage of this ingredient. What is the most appropriate classification of this finding according to ISO 22716:2007 principles for an internal auditor?

Accepted Answer

Major Non-Conformity

Question 25

During an internal audit of a cosmetic manufacturing facility, an auditor discovers a recurring deviation related to the incorrect labeling of a finished product batch. The quality assurance department has implemented a corrective action plan, which includes retraining personnel and updating the labeling procedure. What is the primary focus for the auditor when verifying the effectiveness of this corrective action?

Accepted Answer

Confirmation that the implemented corrective actions have demonstrably eliminated the identified root cause of the labeling deviation and prevented its recurrence.

Question 26

During an internal audit of a cosmetic manufacturing facility, an auditor discovers that a specific batch of finished product, \"Radiant Glow Serum Batch #RG789,\" cannot be fully traced back to its originating raw material lot numbers due to an incomplete entry in the electronic batch record system. The company\'s quality manager provides a corrective action plan that includes updating the batch record software to enforce mandatory entry of all raw material lot numbers. Which of the following actions by the auditor best demonstrates verification of the effectiveness of this corrective action?

Accepted Answer

Selecting a newly manufactured batch of "Radiant Glow Serum" and verifying that its batch record accurately and completely includes all required raw material lot numbers.

Question 27

An internal auditor is reviewing the storage practices for finished cosmetic products at a manufacturing facility. The auditor observes that a significant quantity of a popular facial serum is being held in a warehouse section adjacent to raw materials that have recently undergone a pest control treatment. While the finished products are packaged, the auditor is concerned about potential indirect exposure risks. Considering the principles of ISO 22716:2007, which of the following represents the most critical deficiency in the current storage arrangement from a finished product quality and safety perspective?

Accepted Answer

The proximity of finished products to raw materials undergoing pest control treatments, potentially leading to indirect contamination or odor absorption.

Question 28

An internal auditor conducting a routine audit of a cosmetic manufacturing facility discovers that Batch #789-B, produced in a Class C cleanroom, has tested positive for a specific bacterial strain at a level significantly above the established in-process limit for microbial load. The batch was intended for a sensitive skin product. What is the most critical area for the auditor to investigate immediately to determine the root cause of this non-conformance?

Accepted Answer

The validation status and execution records of the cleaning and disinfection procedures for the specific equipment used in Batch #789-B's production and the cleanroom environment.

Question 29

During an internal audit of a cosmetic manufacturing facility, an auditor observes a significant quantity of a key active ingredient, designated as \"Ingredient X,\" stored in the designated raw material receiving area. Upon closer examination, it is noted that this batch of Ingredient X is missing its unique batch identification number directly on the container and the accompanying Certificate of Analysis (CoA) is not readily available at the point of storage. The facility\'s documented procedure for raw material reception mandates that all incoming materials must be clearly identified with a batch number and accompanied by a valid CoA before being moved to the approved storage area. Considering the auditor\'s role in assessing the effectiveness of the Quality Management System according to ISO 22716:2007, what is the most appropriate immediate action for the auditor to take?

Accepted Answer

Initiate a detailed investigation into the established procedures for raw material reception and identification, examining the root cause of the missing documentation and identifying any systemic gaps.

Question 30

An internal audit at a cosmetic manufacturing facility reveals that a specific batch of a key botanical extract, identified as Raw Material Batch R-105, has been found to contain a microbial contaminant exceeding acceptable limits. This extract is used in multiple product formulations. What is the most critical immediate audit finding an internal auditor should focus on to ensure compliance with ISO 22716:2007 regarding consumer safety and product integrity?

Accepted Answer

Confirmation that finished product batch records accurately identify all finished goods manufactured using Raw Material Batch R-105.

ISO 22716:2007 - Cosmetics GMP Internal Auditor Free Practice Test — 30 Questions

The free lane is only the front row

How to Use This ISO 22716:2007 - Cosmetics GMP Internal Auditor Practice Test

About the ISO 22716:2007 - Cosmetics GMP Internal Auditor Practice Test

Practice Method for This Page

Frequently Asked Questions about ISO 22716:2007 - Cosmetics GMP Internal Auditor

Is this ISO 22716:2007 - Cosmetics GMP Internal Auditor practice test really free?

How many questions are on the real ISO 22716:2007 - Cosmetics GMP Internal Auditor exam?

What score should I target before scheduling?

Preparing for ISO 22716:2007 - Cosmetics GMP Internal Auditor? Now land the interview.

More Study Resources for ISO 22716:2007 - Cosmetics GMP Internal Auditor